Hypericin/Povidone

N/A

Report date: 2022/12/27 09:46:34

Base Information

Drug NameHypericin/Povidone
Drug Alias NameHypericin+PovidonePovidone+HypericinHypericin+Povidone,Povidone/Hypericin,Povidone+HypericinPovidone/Hypericin
ClassificationSmall molecules
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPlanta Naturstoffe
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A